 | Up a level |
2021
Hartlapp, I., Valta-Seufzer, D., Siveke, J., Alguel, H., Goekkurt, E., Siegler, G. M., Martens, U. M., Waldschmidt, D., Pelzer, U., Fuchs, M., Kullmann, F., Boeck, S., Ettrich, T. J., Held, S., Keller, R., Anger, F., Germer, C-T., Stang, H. A., Heinemann, V. and Kunzmann, V. (2021). Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113). Ann. Oncol., 32. S. S1091 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Rau, B., Lang, H., Konigsrainer, A., Gockel, I., Rau, H-G., Seeliger, H., Lerchenmuller, C., Reim, D., Wahba, R., Angele, M., Heeg, S., Keck, T., Weimann, A., Topp, S., Piso, P., Brandl, A., Trips, E., Heinemann, V. and Thuss-Patience, P. C. (2021). The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial). Ann. Oncol., 32. S. S1040 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2018
Haas, M., Waldschmidt, D., Stahl, M., Reinacher-Schick, A., Freiberg-Richter, J., Kaiser, F., Kanzler, S., Frickhofen, N., Seufferlein, T., Dechow, T., Mahlberg, R. J. C., Malfertheiner, P., Illerhaus, G., Kubicka, S., Held, S., Westphalen, C. B., Kruger, S., Boeck, S. and Heinemann, V. (2018). Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT). Ann. Oncol., 29. S. 243 - 244. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Modest, D. P., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C. J., Gebauer, B., Modest, H. I., Held, S., Folprecht, G., Heinemann, V. and Neumann, U. P. (2018). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. Eur. J. Cancer, 88. S. 77 - 87. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
2017
Modest, D. P., Denecke, T., Pratschke, J., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C. J., Gebauer, B., Stintzing, S., Modest, H. I., Held, S., Folprecht, G., Heinemann, V. and Neumann, U. P. (2017). Central evaluation for surgical treatment options in FIRE-3-updated results and impact on overall survival. Oncol. Res. Treat., 40. S. 122 - 123. BASEL: KARGER. ISSN 2296-5262